自发性细菌性腹膜炎预防治疗的问题及对策
被引量:2
摘要
口服氟喹诺酮类抗菌药物,选择性肠道去污染是预防自发性细菌性腹膜炎(SBP)的重要措施。但由此而诱发耐药菌株产生,并使SBP或其他感染的病原菌株发生变化。进一步筛选SBP的危险因素,严格控制预防性抗菌治疗的对象,可能是解决问题的对策。
参考文献20
-
1[1]Thuluvath PJ et al. Am J Gastroenterol, 2001; 96(4): 1232~1236
-
2[2]Dhiman RK et al. Am J Gastrenterol, 2000; 95(1): 233~238
-
3[3]Chu CM. Am J Gastroenterol, 2000; 95(8): 2126~2127
-
4[4]Garcia-Tsao G. Gestroenterology, 1999; 117(2): 495~499
-
5[5]Piddocle LJV. BMJ, 1999; 317: 1029~1030
-
6[6]Aparicio JR et al. Med Clin, 1999; 113(7): 241~245
-
7[7]Ortiz J et al. Hepatology, 1999; 29(4): 1004~1069
-
8[8]Eledrisi MS et al. Am J Gastroenterol, 2000; 95(4): 1110~1111
-
9[9]de la Fuente Aguade J et al. Infection, 1999; 27(3): 224~227
-
10[10]Sabat M et al. Am J Gastroenterol, 1998; 93(12): 2457~2462
同被引文献36
-
1李咏梅,贺俊花.益生菌预防肝硬化自发性腹膜炎疗效观察[J].中国误诊学杂志,2009,9(3):576-577. 被引量:4
-
2刘芙成,斯锞.双歧杆菌联合乳果糖对自发性细菌性腹膜炎的预防作用[J].临床荟萃,2005,20(20):1174-1175. 被引量:3
-
3Chang CS,Yang SS,Kao CH,et al.Small intestinal bacterial cvergrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis[J].Scand J Gastroenterol,2001,36(1):92-96.
-
4Femandez J,Navasa M,Gomez J,et al.Bacterial infections in cirrhosis:epidemiological changes with invasive procedures and norfloxacin prophylaxis[J].Hepatology,2002,35(1):140-148.
-
5Campillo B,Dupeyron C,Richardet JP.Epidemiology of hospital-acquired infections in cirrhotic patients:effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis[J].Epidemiol Infect,2001,127(3):443-450.
-
6Kirpich IA, Mcclain CJ. Probiotics in the treatment of the liverdiseases[J]. J Am Coll Nutr,2012,31(1): 14-23.
-
7European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis [J]. JHepatol,2010,53 (3): 397-417.
-
8Runyon BA,AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis : an update [J]. Hepatology,2009,49(6): 2087-2107.
-
9Pande C,Kumar A,Sarin SK. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis : a double-blind placebo-controlled randomized-controlled trial[J]. Eur J Gastroenterol Hepatol,2012,24(7): 831-839.
-
10Imani Fooladi AA,Mahmoodzadeh Hosseini H,Nourani MR,et al. Probiotic as a novel treatment strategy against liver disease [J]. Hepat Mon,2013,13(2): e7521.
二级引证文献4
-
1曹建彪,王伟芳.益生菌在肝硬化患者中的应用[J].中国实用内科杂志,2016,36(9):754-757. 被引量:11
-
2卢世云,潘秀珍.益生菌对肝硬化自发性腹膜炎的预防及对肝功能的影响[J].中国微生态学杂志,2018,30(10):1181-1184. 被引量:6
-
3唐岚,梁洁玲,钟备,邓英,王鹏.微生态制剂辅助治疗肝硬化自发性腹膜炎的效果观察[J].临床医学,2019,0(5):102-104. 被引量:3
-
4王凤梅,贾文玲,董玉慧,陈多兆,白兆娟.乳果糖联合双歧杆菌三联活菌肠溶胶囊对肝硬化SBP患者疗效观察[J].中国继续医学教育,2019,11(7):132-134. 被引量:3
-
1刘树人,罗显荣,陈汉先,欧阳石,李灼亮.选择性肠道去污染对肝硬化自发性细菌性腹膜炎肠黏膜通透性的影响[J].胃肠病学和肝病学杂志,2011,20(8):719-721. 被引量:4
-
2苏永辉,杨禄坤,蔡潮农,周文英,侯冰宗.选择性肠道去污染对肝硬化大鼠肝门阻断细菌移位、内毒素血症的影响[J].中华普通外科学文献(电子版),2014,8(2):19-22.
-
3夏晴,慕高萌.实行药品通用名遇到的问题及对策[J].当代医学,2009,15(34):36-36. 被引量:1
-
4郭醒华.慢性病防治面临的问题及对策[J].中国公共卫生,1997,13(4):253-254. 被引量:14
-
5李秀梅,胡大一.氯吡格雷在冠心病中的应用[J].中国临床药理学杂志,2010,26(1):75-78. 被引量:20
-
6杨念生.系统性红斑狼疮的治疗:问题及对策[J].中华风湿病学杂志,2016,20(11):721-724. 被引量:5
-
7王金红.有机磷中毒患者的护理[J].中国医药指南,2013,11(13):455-456. 被引量:3
-
8王清和,邱海英.试论在艾滋病防治工作中面临的社会问题及对策[J].中国公共卫生管理,1996,12(3):203-204.
-
9郝普,田爱廷,等.病毒性乙型肝炎及黄疸病人手术麻醉中的问题及对策[J].吉林医学信息,1994(11):8-8.
-
10杨世明.浅谈肺炎支原体肺炎的诊治问题及对策[J].中国医药导刊,2009,11(3):519-519. 被引量:3